Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.

Raphael, Jacques; Richard, Lucie; Lam, Melody; Blanchette, Phillip S; Leighl, Natasha B; Rodrigues, George; Trudeau, Maureen E; Krzyzanowska, Monika K

Raphael, Jacques; Richard, Lucie; Lam, Melody; Blanchette, Phillip S; Leighl, Natasha B; Rodrigues, George; Trudeau, Maureen E; Krzyzanowska, Monika K.

Afiliação

Raphael J; Division of Medical Oncology, London Regional Cancer Program, Western University, London, ON, Canada.
Richard L; ICES, London, ON, Canada.
Lam M; ICES, London, ON, Canada.
Blanchette PS; ICES, London, ON, Canada.
Leighl NB; Division of Medical Oncology, London Regional Cancer Program, Western University, London, ON, Canada.
Rodrigues G; ICES, London, ON, Canada.
Trudeau ME; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Krzyzanowska MK; Division of Radiation Oncology, London Health Sciences Centre, London, ON, Canada.

Oncologist ; 27(8): 675-684, 2022 08 05.

Article em En | MEDLINE | ID: mdl-35552444

Assuntos

Neoplasias de Cabeça e Pescoço; Melanoma; Feminino; Humanos; Fatores Imunológicos; Imunoterapia; Ontário/epidemiologia; Estudos Retrospectivos

Palavras-chave

advanced cancer; immunotherapy; population-based study; universal healthcare system; utilization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google